Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Selling intensifies in the final hours
Mon, 24 May Closing

While the Indian markets traded well above the dotted line for the larger part of the day, selling activity across index heavyweights intensified in the final trading hours to pare most of the gains that were made. While the BSE Sensex closed higher by around 24 points (up 0.2%), the NSE Nifty gained around 13 points (up 0.3%). While the BSE Midcap ended flat, the Smallcap index notched gains of 1%. Gains were largely seen in oil & gas stocks while metals and auto stocks were at the receiving end.

As regards global markets, Asian indices closed mixed today while the European indices have also opened on a mixed note. The rupee was trading at Rs 46.94 to the dollar at the time of writing.

Sun Pharma announced its FY10 results a while ago. The company's topline declined by 4% YoY during the year. This was largely due to the 7% YoY decline in domestic formulations sales and the 12% YoY decline in international formulations. As far as the former is concerned, the decline in sales was largely due to a one time impact in 4QFY09. Thus, on excluding the same, domestic formulations sales grew by 15% YoY. As far as international formulations are concerned, sales declined largely due to the drop in revenues from the US business. Having said that, international formulations grew by 29% YoY during the year. The company's operating margins declined by 10.2% largely due to the higher margins that the company enjoyed in FY09 due to some exclusivity period for some products, which was not present this year. Decline in operating profits and higher depreciation charges led to the 26% YoY decline in net profits. The stock closed higher today.

Cement stocks closed mixed today. While Ambuja Cement and India Cements found favour, Madras Cements closed in the red. Madras Cement announced its FY10 results. Sales for the full year grew by 14% YoY. The operating profits were higher by 10.6% YoY as margins fell by 1%. Higher raw material costs, employee costs and transport & handling charges led to the decline in operating margins during the year. Net profits for the year declined by 3% YoY due to higher interest costs and depreciation charges. Board announced a final dividend of Rs 0.5 per share along with the interim dividend of Rs 1.5 per share.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Selling intensifies in the final hours". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.